Mechanism of Huangqi Sanxian Decoction Inhibiting Osteoclast Differentiation Based on Network Pharmacology

Osteoclasts (OCs) have been the unique cell type exhibiting the bone-resorption activity in body. It is important to identify drugs to resist osteoclastogenesis to manage the bone-loss disorders. Huangqi Sanxian decoction (HQSXD) is utilized for the treatment of postmenopausal osteoporosis (PMOP) fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jian-Xin, Cai, Xiao-Qun, Zhao, Ze-Hao, Deng, Yu, Zhou, Zhi-Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225917/
https://www.ncbi.nlm.nih.gov/pubmed/35754697
http://dx.doi.org/10.1155/2022/8769531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225917/
https://www.ncbi.nlm.nih.gov/pubmed/35754697
http://dx.doi.org/10.1155/2022/8769531

Ejemplares similares